— Know what they know.
Not Investment Advice

THCT OTC

THC Therapeutics, Inc.
1W: -50.0% 1M: -50.0% 3M: -66.7% YTD: +200.0% 1Y: -40.0% 3Y: +1300.0% 5Y: -80.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 44 · $11660 mcap · 30M float · 0.0014% daily turnover · Short 62% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.1
Volume227,611
Avg Volume424
Beta7.53
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOScott A. Cox
Employees1
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2017-01-23
Websitethct.io
203 S. Church Street
Jacksboro, TX 76458
US
833 420 8428
About THC Therapeutics, Inc.

THC Therapeutics, Inc. is a company active in the wellness sector, primarily engaged in developing the dHydronator. This innovative device functions as a sanitizing herb dryer, specifically designed for the efficient drying and cleansing of freshly harvested cannabis, as well as a variety of other herbs, flowers, and tea leaves. Established in 2007, the organization was initially known as Millennium Blockchain, Inc. before officially changing its name to THC Therapeutics, Inc. in September 2018. The company's corporate headquarters are located in Las Vegas, Nevada.

Recent Insider Trades

NameTypeSharesPriceDate
TANAKA HIRO 0 — 2013-11-14
Smith Adrian J R 1,000,000 $0.03 2013-09-10
MANN JAMIE 0 — 2013-09-10
Ho Eden P-Purchase 5,000 $0.42 2010-06-07
Ho Eden P-Purchase 19,001 $0.52 2010-05-28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms